Wednesday, January 27, 2021
Monday, January 25, 2021
COVID-19 Vaccine Phases and Planning in Chicago
COVID-19 Vaccine Phases and Planning in Chicago
There will be a phased roll-out of the COVID-19 vaccine in Chicago with a very limited supply at the beginning, so certain groups will be prioritized. Everyone is encouraged to get vaccinated as soon as it’s their turn. Supplies will increase over time and all adults will be able to get vaccinated later in 2021. Once a vaccination phase begins, people in that phase are eligible to receive the COVID-19 vaccine indefinitely. Tentative dates are dependent on vaccine supply.
Source: https://www.chicago.gov/
Outside Chicago, please check Illinois Department of Health website:
How the Vaccine Rollout Is Going in Your State:
U.S. COVID-19 Vaccine Administration by Vaccine Type:
* Pfizer-BioNTech
* Moderna
Saturday, January 23, 2021
How has WHO responded to COVID-19
How has WHO responded to COVID-19
World Health Organization (WHO)
More information: http://www.who.int/COVID-19
How long does immunity against the coronavirus last? | COVID-19 Special
How long does immunity against the coronavirus last? | COVID-19 Special
Source: https://youtu.be/GuxkNSCWOxg
Friday, January 22, 2021
COVID-19 treatment(s) given to Trump
8 drugs Trump has been given for his COVID-19 treatment
Monday, October 5th, 2020
Since President Donald Trump tested positive for COVID-19 Oct. 1, he has been given a variety of drugs intended to shorten his recovery time and ease symptoms.
Though no drug has been FDA approved to treat the virus, a handful have shown positive results in clinical trials. The president has been given drugs that are being tested in clinical trials and aren't available to the general public.
The eight drugs the president reportedly has been given:
Dexamethasone — President Trump was prescribed the steroid dexamethasone, a drug commonly used to treat asthma, rheumatoid arthritis and certain cancer, on Oct. 3. Sean Conley, DO, the president's physician, said the steroid was given to him in response to his blood oxygen levels dropping twice to 93 percent, according to STAT.
The steroid is typically recommended for hospitalized patients who need oxygen or are on ventilators. A study released in June showed that dexamethasone reduced deaths by one-third for those who had been sick for more than a week and were on mechanical ventilators, but had no impact on patients receiving no respiratory support. The study suggested that the drug may do more harm than good for patients with milder COVID-19 cases, since steroids hamper the body's immune system.
The drug is typically given to patients with severe COVID-19 to prevent an immune system overreaction. Some experts called it a "major breakthrough" for COVID-19 treatment, as it was the first drug shown to improve survival rates.
Remdesivir — President Trump was given his first dose of remdesivir Oct. 2, and he will be given a five-day course, CNN reported. Remdesivir, made by Gilead (who gave it the brand name of Veklury), was granted emergency use authorization by the FDA on May 1 after a study showed it caused a 31 percent faster recovery time compared to a placebo.
Remdesivir is an intravenous drug that works by targeting the system coronaviruses use to replicate themselves. It has been previously tested for Ebola, but hasn't been officially approved in any country. The FDA expanded its emergency use authorization for remdesivir Aug. 28, allowing it to be used on all hospitalized patients. It had previously only been authorized for those on ventilators or with low blood oxygen levels.
Regeneron's monoclonal antibody — On Oct. 2, the White House released a letter saying the president received a single 8-gram dose of Regeneron's monoclonal antibody cocktail, called REGN-COV2, the highest dose of the drug being tested in late-stage clinical trials, according to Politico.
Regeneron said in a Sept. 29 news release that a high dose of the drug caused the level of the virus to decrease in patients in an early clinical trial, indicating it may help COVID-19 patients recover faster. The trial seemed to show the drug had a bigger effect on patients who were infected with the virus but hadn't created high levels of their own antibodies against the virus. The drug uses synthetic versions of the antibodies patients' bodies create when they recover from a disease. In July, Regeneron received $450 million from Operation Warp Speed, the White House's task force to expedite COVID-19 vaccine development, to manufacture thousands of doses of the drug.
Regeneron CEO Leonard Schleifer, MD, PhD, told The New York Times that President Trump's medical staff reached out to the company for permission to use the drug, and that it was cleared with the FDA. Mr. Schleifer has known the president casually for many years and is a member of his golf club in Westchester County, N.Y., according to the Times.
Zinc — President Trump also has been given zinc, according to the Times, which helps the immune system fight outside bacteria and viruses. Zinc is an essential mineral that is naturally present in some foods and is available as a dietary supplement. There is no evidence that zinc helps fight COVID-19, and the FDA has issued warning letters to some companies that have tried to claim there's a link between zinc products and reduced risk of COVID-19.
Vitamin D — President Trump has been given vitamin D, the Times reported, which is good for bone health. There is no evidence vitamin D directly reduces the risk of COVID-19, and the FDA has sent warning letters to companies trying to sell vitamin D products as COVID-19 treatments. Vitamin D can also help reduce inflammation, according to the National Institutes of Health.
Famotidine — The generic name for Pepcid, famotidine is commonly used to treat ulcers, heartburn, indigestion and reduces the amount of acid in the stomach. A clinical trial testing the drug in hospitalized COVID-19 patients in New York wasn't able to recruit enough patients to properly evaluate its impact, according to Science.
Melatonin — Commonly used to treat insomnia, some studies have suggested that melatonin could also help COVID-19 patients with diabetes and obesity, according to CNN.
"The ability of melatonin to decrease viral infections in obese and diabetic patients is attributed to its characterists, such as potent antioxidant effects, improving the endogenous antioxidant system, immunomodulatory, and the strong anti-inflammatory capability," according to researchers from Mansoura University in Egypt.
A health summary for President Trump released in June showed that he was obese, at 244 pounds, the Times reported.
Aspirin — Commonly given to older patients to prevent heart disease, aspirin is also a popular painkiller. It can reduce the risk of blood-clotting, and evidence has shown COVID-19 can trigger blood clots in some patients. The president has mild heart disease, the Times reported.
Thursday, January 21, 2021
CoronaVirus Info - Covid-19
- Covid19 Health Center / TESTING Center
- Johns Hopkins University (Map and Statistic)
- ncov2019.live (Map and Statistic)
- CDC Centers for Disease Control and Prevention
- WHO World Health Organization
- Imigrasi Indonesia - Travel during Covid
- Kementerian Kesehatan Indonesia - Covid
- Hotline KBRI - KJRI
- KBRI Washington DC: +1 202 569 7996
- KJRI Chicago: +1 312 547 9114
- KJRI Houston: +1 346 932 7284
- KJRI Los Angeles: +1 213 590 8095
- KJRI New York: +1 347 806 9279
- KJRI San Francisco: +1 415 875 0793
- Apply for a Visa to visit Indonesia
Sunday, January 3, 2021
Friday, January 1, 2021
LIVE: Keterangan Pers Menteri Luar Negeri, Kantor Presiden, 28 Desember ...
*Antisipasi Varian Baru Covid-19, Pemerintah Tutup Sementara Perjalanan WNA ke Indonesia*
Adanya informasi ditemukannya _strain_ atau varian baru virus Covid-19, yang menurut berbagai data ilimiah memiliki tingkat penyebaran lebih cepat, Pemerintah memutuskan untuk menutup sementara masuknya warga negara asing ke Indonesia sebagai upaya pencegahan.
"Rapat kabinet terbatas tanggal 28 Desember 2020 memutuskan untuk menutup sementara dari tanggal 1 sampai 14 Januari 2021 masuknya warga negara asing atau WNA dari semua negara ke Indonesia," ujar Menteri Luar Negeri Retno Marsudi dalam konferensi pers pada Senin, 28 Desember 2020 di Kantor Presiden.
Bagi WNA yang tiba di Indonesia terhitung per tanggal 28 Desember hingga 31 Desember 2020 mendatang, diberlakukan aturan sesuai ketentuan dalam adendum Surat Edaran Satuan Tugas Penanganan Covid-19 Nomor 3 Tahun 2020. Melalui ketentuan tersebut, WNA yang akan memasuki Indonesia diwajibkan untuk menunjukkan hasil tes RT-PCR dari negara asal dan melakukan pemeriksaan ulang setibanya di Indonesia.
"Menunjukkan hasil negatif melalui tes RT-PCR di negara asal yang berlaku maksimal 2x24 jam sebelum jam keberangkatan dan dilampirkan pada saat pemeriksaan kesehatan atau e-HAC _(electronic health alert card)_ internasional Indonesia. Pada saat kedatangan di Indonesia, melakukan pemeriksaan ulang RT-PCR dan apabila menunjukkan hasil negatif, maka WNA melakukan karantina wajib selama lima hari terhitung sejak tanggal kedatangan," ucap Menlu yang hadir didampingi Juru Bicara Pemerintah untuk Penanganan Covid-19 Prof Wiku Adisasmito.
Setelah melalui karantina selama lima hari tersebut, WNA akan melakukan pemeriksaan ulang dengan metode RT-PCR. Apabila memperoleh hasil negatif, maka pengunjung diperkenankan untuk meneruskan perjalanan.
Sementara itu, sesuai dengan Undang-Undang Nomor 6 Tahun 2011 pasal 14, warga negara Indonesia (WNI) tetap diizinkan untuk kembali ke Indonesia dengan ketentuan adendum dari surat edaran yang sama dengan ketentuan yang berlaku untuk WNA.
Para WNI yang akan kembali ke Indonesia juga diminta untuk menunjukkan hasil negatif melalui tes RT-PCR dari negara asal yang berlaku maksimal 2x24 jam sebelum jam keberangkatan dan dilampirkan saat pemeriksaan kesehatan atau e-HAC. Setibanya di Indonesia, Menlu menjelaskan, WNI juga harus melakukan pemeriksaan ulang dan karantina wajib selama lima hari sebelum kembali dilakukan pemeriksaan ulang dengan hasil negatif sehingga dapat meneruskan perjalanan.
"Pada saat kedatangan di Indonesia, melakukan pemeriksaan ulang RT-PCR dan apabila menunjukkan hasil negatif, maka melakukan karantina wajib selama lima hari terhitung sejak tanggal kedatangan di tempat akomodasi karantina yang telah disediakan oleh pemerintah. Setelah karantina lima hari, WNI melakukan pemeriksaan ulang RT-PCR dan apabila hasil negatif, maka diperkenankan meneruskan perjalanan," tuturnya.
Untuk diketahui, kebijakan penutupan sementara perjalanan WNA ke Indonesia ini dikecualikan bagi kunjungan resmi pejabat setingkat menteri dan tingkat di atasnya. Kunjungan tersebut pun juga dilakukan dengan menerapkan protokol kesehatan yang sangat ketat.
Kebijakan tersebut akan segera dituangkan dalam surat edaran baru Satuan Tugas Penanganan Covid-19.
Jakarta, 28 Desember 2020
Biro Pers, Media, dan Informasi Sekretariat Presiden
Website: https://www.presidenri.go.id
YouTube: Sekretariat Presiden
#IndonesiaTaste
#IndonesiaAsiaTravel
#IndoChicago
- Covid19 Health Center / TESTING Center
- Johns Hopkins University (Map and Statistic)
- ncov2019.live (Map and Statistic)
- CDC Centers for Disease Control and Prevention
- WHO World Health Organization
- Hotline KBRI - KJRI
- KBRI Washington DC: +1 202 569 7996
- KJRI Chicago: +1 312 547 9114
- KJRI Houston: +1 346 932 7284
- KJRI Los Angeles: +1 213 590 8095
- KJRI New York: +1 347 806 9279
- KJRI San Francisco: +1 415 875 0793
Subscribe to:
Posts (Atom)
Are you travelling to Indonesia ?
Indonesian Events in Chicago: IndoChicago Taste of Indonesia Events in USA Ticket Pulang Kampung: Hubungi Tedjo Express Travel/ or Ind...
-
Press Release: Foreigners from 23 Countries are Eligible for Visa on Arrival for Tourism Visa On Arrival atau Visa Kunjungan ke INDONESI...
-
JANUARY 2022 Update Karantina dengan jangka waktu antara 14 atau 10 x 24 jam dari negara/wilayah asal kedatangan selain dari negara yang mem...
